ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

April 10, 1992

Did The Dog Eat It? NIH Fails To Turn In A Prostate Cancer Plan Assigned By Senate

April 23, 1999

Program Project Guidelines Listed

March 18, 1977

ONS Annual Meeting To Highlight Nursing Progress In ‘70s, ‘80s

April 20, 1990